Brian Hahn

Brian Hahn is the current CFO & SVP at GlycoMimetics. Prior to this, they were Assistant Controller at OpGen from September 2009 to February 2010. From January 2002 to September 2009, they were Executive Director-Finance at MiddleBrook Pharmaceutical. In February 2016, Brian became an advisory committee member for the Committee on Small and Emerging Companies at the U.S. Securities and Exchange Commission, a position they held until July 2017.

Brian Hahn has an MBA from the University of Maryland Global Campus and a BBA in Accounting from Shenandoah University.

Their manager is Harout Semerjian, President & CEO. and Stephanie Irish - VP, Accounting reports to Brian Hahn. Some of their coworkers include Christian Dinneen-Long - VP & Corporate Counsel, Company Secretary, John Magnani - SVP, Research & Chief Scientific Officer, and Bruce Johnson - CCO & SVP.